Revolution Medicines, Inc. <RVMD.O>: BofA Global Research Raises Price Objective to $265 From $225
RVMD•Related News
Black Hills Corp <BKH.N>: BofA Global Research Raises Price Objective to $97.00 from $87.00
BKH•
US stocks-Wall St futures rise as AI stocks rally, crude prices fall
SPY•
QIA, J.P. Morgan Asset Management sign USD 20 billion strategic partnership
JPM•
Priority Technology to go private in $1.6 billion CEO-led deal
PRTH•
Perfect Corp partners with Lagardère Travel Retail to deploy Skincare Pro at European airports
PERF•